Considering the elevated levels of CD52 expression in the adipocytes of obese and obese T2DM patients, it is likely that this may lead to an increase in the ratio of CD4+CD52high T cells to CD4+CD52low T cells, thereby promoting the development of diabetes. The gene discussed is CD4; the disease is type 2 diabetes mellitus.